(NYSE: NGVT) Ingevity's forecast annual revenue growth rate of 2.05% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.76%.
Ingevity's revenue in 2025 is $1,324,800,000.On average, 1 Wall Street analysts forecast NGVT's revenue for 2025 to be $49,010,687,040, with the lowest NGVT revenue forecast at $49,010,687,040, and the highest NGVT revenue forecast at $49,010,687,040. On average, 1 Wall Street analysts forecast NGVT's revenue for 2026 to be $50,214,074,445, with the lowest NGVT revenue forecast at $50,214,074,445, and the highest NGVT revenue forecast at $50,214,074,445.
In 2027, NGVT is forecast to generate $51,709,192,130 in revenue, with the lowest revenue forecast at $51,709,192,130 and the highest revenue forecast at $51,709,192,130.